The aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasis
The aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasis
Patients with ER-negative breast tumors are among the most difficult to treat and exhibit low survival rates due, in part, to metastasis from the breast to various distal sites. Aryl hydrocarbon receptor (AHR) ligands show promise as antimetastatic drugs for estrogen receptor (ER)-negative breast cancer.